Diffuse Gastrointestinal Motor Compromise in Patients with Scleroderma: Utility of Minimally Invasive Techniques

Area of Science:

• Gastroenterology
• Rheumatology
• Systemic Inflammatory Disorders

Background:

• Scleroderma frequently impacts the gastrointestinal tract in up to 90% of patients.
• Understanding the extent and nature of GI compromise is crucial for patient management.

Purpose of the Study:

• To characterize esophageal, gastric, and intestinal compromise in scleroderma patients using minimally invasive techniques.
• To investigate the association between GI involvement, symptoms, and disease severity.

Main Methods:

• Recruited 30 patients with systemic sclerosis based on American College of Rheumatology criteria.
• Employed a four-day protocol: esophageal manometry, intestinal manometry, electrogastrography, and hydrogen breath test.
• Utilized Mann-Whitney and chi-squared tests for statistical analysis.

Main Results:

• High prevalence of GI compromise: 80% intestinal, 76% esophageal, 66% bacterial overgrowth.
• 23% exhibited simultaneous esophageal, gastric, and intestinal involvement.
• GI compromise correlated with skin involvement but not directly with GI symptoms.

Conclusions:

• Gastrointestinal involvement is a frequent complication in scleroderma.
• The presence of GI compromise is largely independent of patient symptoms and clinical characteristics, with the exception of skin involvement.